Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma

Journal of Nuclear Medicine

Volumn 38, Issue 10, 1997, Pages 1546-1551

  Maini, Carlo L ^a   Tofani, Anna ^a   Sciuto, Rosa ^a   Semprebene, Alessandro ^a   Cavaliere, Renato ^a   Mottolese, Marcella ^a   Benevolo, Maria ^a   Ferranti, Francesca ^a   Grandinetti, Maria L ^a   Vici, Patrizia ^a   Lopez, Massimo ^a   Botti, Claudio ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Breast carcinoma; Breast scintigraphy; Neoadjuvant chemotherapy; Technetium 99m MIBI

Indexed keywords

CD31 ANTIGEN; CYCLINE; CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; ONCOPROTEIN; PROGESTERONE RECEPTOR;

ADVANCED CANCER; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DRUG RESPONSE; HUMAN; IMMUNOHISTOCHEMISTRY; MAMMOGRAPHY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; TECHNETIUM TC 99M SESTAMIBI;

EID: 9844251211     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hortobagyi GN, Spanos W, Montague E, et al. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy and combination chemoimmunotherapy. Int J Radiat Oncol Biol Phys 1983;9:643-650.
2. Hortobagyi GN. Multidisciplinary management of advanced primary and metastatic breast cancer. Cancer 1994;74:416-423.
3. Segel MC, Paulus DD, Hortobagyi GN. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 1988;169:49-54.
4. Cocconi G, Di Blasio B, Alberti G, et al. Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 1984;4:309-313.
5. Moskovic EC, Mansi JL, King MD, et al. Mammography in the assessment of response medical treatment of large primary breast cancer. Clin Radiol 1993;47:339-344.
6. Feldman LD, Hortobagyi GN, Buzdar AU, et al. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 1986;46:2578-2581.
7. Sehweil AM, McKillop JH, Milroy R, et al. Thallium-201 scintigraphy in the staging of lung cancer, breast cancer and lymphoma. Nucl Med Commun 1990;11:263-269.
8. Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18-23.
9. 201Tl. Clin Nucl Med 1992;17:171-176.
10. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784-1789.
11. Piwinica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990;82: 1826-1838.
12. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium-99m agents. Semin Nucl Med 1991;21:173-181.
13. Wackers FJ-TH, Berman DS, Maddahi J, et al. Technetium-99m-hexakis-2-methoxy-isobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-311.
14. Baillet GY, Mena IG, Kuperus JH, et al. Simultaneous technetium-99m-MIBI angiography and myocardial perfusion imaging. J Nucl Med 1989;30:38-44.
15. Hayward JL, Rubens RD, Carbone PP, et al. Assessment of response to therapy in advanced breast cancer. A project of the program on Clinical Oncology of the UICC. Eur J Cancer 1978;14:1291-1292.
16. Hortobagyi GN, Blumenschein GR, Spanos W, et al. Multimodality treatment of locoregionally advanced breast cancer. Cancer 1983;51:763-768.
17. Buzdar A, Montague E, Baker J, et al. Management of inflammatory carcinoma of the breast with combined modality approach: an update. Cancer 1981;47:2537-2542.
18. Davila E, Vogel C. Management of locally advanced breast cancer (stage III): a review. Int Adv Surg Oncol 1984;7:1537-1543.
19. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery and relation therapy. Cancer 1988;62: 2507-2516.
20. 99mTc-sestamibi in tumor imaging. In: Freeman, LM, ed. Nuclear medicine annals. New York: Raven Press; 1994:181-234.
21. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m-sestamibi. Eur J Nucl Med 1994;21:357-362.
22. Piwinica-Worms D, Chiu ML, Budding M, et al. Functional imaging of the multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-984.
23. Kedar RP, Cosgrove DO, Smith IE, et al. Breast carcinoma: measurement of tumor response to primary medical therapy with color Doppler flow imaging. Radiology 1994;190:825-830.